Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:
    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 134,986 251,929 319,053 656,089
Total Sell Value $11,097,511 $21,508,551 $27,661,182 $61,420,002
Total People Sold 5 6 7 7
Total Sell Transactions 9 19 27 56
End Date 2024-04-04 2024-01-02 2023-07-04 2022-07-04

   
Records found: 1285
  Page 39 of 52  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Lawlis V Bryan Director   –       •      –    2016-11-09 4 OE $17.33 $129,975 D/D 7,500 21,360     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-11-08 4 AS $82.83 $5,797,806 D/D (70,000) 323,368     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-11-08 4 OE $21.51 $1,505,700 D/D 70,000 393,368     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-11-07 4 AS $82.52 $5,776,435 D/D (70,000) 323,368     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-11-07 4 OE $21.51 $1,505,700 D/D 70,000 393,368     -
   Mueller Brian SVP, Corporate Controller   •       –      –    2016-10-31 5 A $68.42 $4,242 D/D 62 14,002     -
   Spiegelman Daniel K EVP, Chief Financial Officer   •       –      –    2016-10-31 4 A $68.44 $10,677 D/D 156 43,100     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-10-28 4 AS $81.27 $4,875,990 D/D (60,000) 323,368     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-10-28 4 OE $14.39 $863,400 D/D 60,000 383,368     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-10-27 4 AS $81.34 $4,880,448 D/D (60,000) 323,368     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-10-27 4 OE $14.39 $863,400 D/D 60,000 383,368     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-10-17 4 AS $84.39 $3,516,227 D/D (41,666) 323,368     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-10-17 4 OE $17.54 $730,822 D/D 41,666 365,034     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-10-14 4 AS $86.89 $955,814 D/D (11,000) 323,368     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-10-14 4 OE $17.86 $196,460 D/D 11,000 334,368     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-10-13 4 AS $86.98 $4,620,563 D/D (53,125) 323,368     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-10-13 4 OE $38.59 $2,050,094 D/D 53,125 376,493     -
   Davis George Eric EVP, General Counsel   •       –      –    2016-10-07 4 GD $0.00 $0 D/D 360 70,798     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-09-30 4 AS $92.02 $4,888,780 D/D (53,125) 378,584     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-09-30 4 OE $38.59 $2,050,094 D/D 53,125 431,709     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-09-29 4 AS $93.65 $4,974,901 D/D (53,125) 378,584     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-09-29 4 OE $38.59 $2,050,094 D/D 53,125 431,709     -
   Ajer Jeffrey Robert EVP, Chief Commercial Officer   •       –      –    2016-09-27 4 AS $95.61 $1,765,648 D/D (18,467) 41,342     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-09-16 4 AS $95.25 $9,058,600 D/D (94,791) 378,584     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2016-09-16 4 OE $17.54 $2,780,915 D/D 94,791 420,250     -
  1285 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 39 of 52
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us